The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.
about
Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2State-of-the-science review: does manganese exposure during welding pose a neurological risk?Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesHomologous-pairing activity of the human DNA-repair proteins Xrcc3.Rad51CIron dysregulation in Huntington's diseaseMetals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercuryManganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable FeaturesA study on the role of nitric oxide and iron in 3-morpholino-sydnonimine-induced increases in dopamine release in the striatum of freely moving ratsIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesExpression of novel antioxidant thioredoxin-2 in the rat brainEfflux of iron from the cerebrospinal fluid to the blood at the blood-CSF barrier: effect of manganese exposureIdentification of iron responsive genes by screening cDNA libraries from suppression subtractive hybridization with antisense probes from three iron conditions.Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology.Crystallization and preliminary X-ray diffraction data for the aconitase form of human iron-regulatory protein 1.In vivo evaluation of microglia activation by intracranial iron overload in central pain after spinal cord injuryRole of hepcidin in murine brain iron metabolism.Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.Disentangling in vivo the effects of iron content and atrophy on the ageing human brainAntioxidants as treatment for neurodegenerative disorders.Pirlindole and dehydropirlindole protect rat cultured neuronal cells against oxidative stress-induced cell death through a mechanism unrelated to MAO-A inhibition.Iron in neurodegenerative disorders.The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.Brain T1 intensity changes after levodopa administration in healthy subjects: a voxel-based morphometry study.Modifying effects of the HFE polymorphisms on the association between lead burden and cognitive declineChelators in the treatment of iron accumulation in Parkinson's disease.Effect of oxidative stress induced by intracranial iron overload on central pain after spinal cord injury.The potential application of iron chelators for the treatment of neurodegenerative diseases.Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.Metal attenuating therapies in neurodegenerative disease.Iron toxicity in neurodegeneration.Taurine and central nervous system disorders.Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.Preclinical and Potential Applications of Common Western Herbal Supplements as Complementary Treatment in Parkinson's Disease.Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid.Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells.Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease.The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice.Pattern and associated factors of the neurolathyrism epidemic in Ethiopia.Psychological stress expands low molecular weight iron pool in cerebral cortex, hippocampus, and striatum of rats.Thalamic GABA levels and occupational manganese neurotoxicity: Association with exposure levels and brain MRI.
P2860
Q22064539-9326CB7B-0B2E-4224-94FF-13EED258FFE8Q23910026-3F0E0665-217B-4D89-89D0-3D65BCE1BCBAQ24289511-169F0D2D-5BA9-457C-A61E-9587B92C1A7EQ24598025-2A147A3D-D616-4CF8-91EC-C439D54BBBA6Q26829932-B6D396D1-D800-4F58-A240-F976CCFAE0E4Q26863224-3D08655B-B586-48B9-A322-09CF3C9E2C38Q28082230-42B6DA81-11A1-441B-9651-2996A8AB4E73Q28357153-ED8C952D-BEC7-48EB-B9A7-23F3CE160EE5Q28388335-C174EF7F-D72B-4FE3-8E16-CFE265C7D3EFQ28573217-4A3FB6EB-DEB4-4552-9689-B3C2EA3B364BQ28576031-5F4A5FB3-FD2F-4919-8737-ECC0A9E178A3Q30850746-4C8A87DE-2F26-4911-940E-30C84F1875F2Q31058247-082B6873-0C02-4C38-BE29-30C69EF73C84Q33235195-5FDE66B5-E830-40CD-A256-FA2EF4E4FD04Q33706685-82CFFB18-953A-492F-AA19-232B7F780B8AQ34476015-8D9A32FC-123D-4303-8B60-0E588F91A60BQ34587764-17C60B62-5635-4DE1-9460-0A62B960D083Q34680685-5C9A384B-F1F6-49C5-B6E4-5256796F5459Q34974866-83C8DCA6-C96A-4DCC-B56E-CB05A3849CE6Q35044098-BF71DFE7-4605-48ED-A66E-F706A68CE83DQ35112542-9A904E51-B252-4536-91EF-E0045078CCFDQ35545150-FBAF96A8-29AF-4904-94E3-E3960FA4A989Q35827877-93D737BE-1D10-4276-BD53-95C38D9DBF5BQ35925446-A210AC22-E77E-4C43-B00A-F91EAEFA5B38Q36056203-3C6D5DA5-A347-4331-A893-61E1D0540473Q37633719-780ECA5F-97A0-496A-A9F1-C7E1FCADA5BFQ37846107-BBDC917A-8D3F-4FA1-AC5A-22BA1ED9BE61Q37848245-E8039286-1D50-49E8-BC38-C2A9DE7FF4EBQ37957126-36E44485-703A-4123-B498-535D22A14EB7Q37982648-3FC57468-704A-464E-91A1-FA64CCEF4D99Q38035753-6534E798-88E2-4A39-B700-AC4C651EAAD6Q38074340-143485FC-7653-4ECB-BC0D-877AB9895ABAQ39091914-6CD8E14A-BC26-4659-BE4F-9A8987DC46EBQ42489173-168D59F1-8106-4131-9A89-4576AFE4E4C4Q42490786-AA247340-2C6C-43F2-9D8B-3AE87BCD840FQ43264695-B67AB5C3-14FF-4F7E-A43B-CBD05E6F571FQ46322674-611C36C2-3ED6-4A13-83AB-E7F5248CEDDBQ46496845-F45189BC-AB20-4DA8-9552-45F6FA840773Q47350061-B2B67705-D3A5-4DD9-B017-B327E3B58FA6Q48126463-D6372CD2-3437-46C9-8AFF-7CCA35E807A6
P2860
The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The role of iron in neurodegen ...... herapy of Parkinson's disease.
@ast
The role of iron in neurodegen ...... herapy of Parkinson's disease.
@en
The role of iron in neurodegen ...... herapy of Parkinson's disease.
@nl
type
label
The role of iron in neurodegen ...... herapy of Parkinson's disease.
@ast
The role of iron in neurodegen ...... herapy of Parkinson's disease.
@en
The role of iron in neurodegen ...... herapy of Parkinson's disease.
@nl
altLabel
The Role of Iron in Neurodegeneration
@en
prefLabel
The role of iron in neurodegen ...... herapy of Parkinson's disease.
@ast
The role of iron in neurodegen ...... herapy of Parkinson's disease.
@en
The role of iron in neurodegen ...... herapy of Parkinson's disease.
@nl
P1433
P1476
The role of iron in neurodegen ...... herapy of Parkinson's disease.
@en
P2093
Jellinger KA
P304
P356
10.2165/00002512-199914020-00004
P577
1999-02-01T00:00:00Z
P6179
1046738317